This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (40)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Joseph Frucht-Pery, MD; Jacob Pe'er, MD

Arch Ophthalmol. 1996;114(10):1261-1264.

Abstract
A patient who had primary acquired melanosis with marked atypia shown on histological studies received topical 0.02% mitomycin C for 2 weeks and 0.04% mitomycin C for an additional 2 weeks. Conjunctival biopsy specimens were obtained to evaluate the efficacy of the treatment. After the first course of mitomycin C administration, some decrease of conjunctival pigmentation was seen, and histological studies disclosed a lower degree of atypia. After the second application of mitomycin C, the pigmentation disappeared except for one small spot that contained only a few typical melanocytes on histological study. The clinical findings did not change during 7 months of follow-up. No adverse reactions to topical mitomycin C occurred except for mild conjunctival hyperemia at the end of the courses of treatment. Administration of topical mitomycin C may be an effective medical treatment for primary acquired melanosis with atypia.

Author Affiliations
From the Department of Ophthalmology, Hadassah University Hospital, Jerusalem, Israel. The authors have no proprietary interest in the development or marketing of this or a competing drug.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Clinical mapping of conjunctival melanomas
Damato and Coupland
Br J Ophthalmol 2008;92:1545-1549.
ABSTRACT | FULL TEXT  

CASE 4. A Black Eye: Melanoma In Situ of the Conjunctiva
Kyto and Kivela
JCO 2006;24:1013-1014.
FULL TEXT  

Epiphora as a side effect of topical mitomycin C
Kopp and Seregard
Br J Ophthalmol 2004;88:1422-1424.
ABSTRACT | FULL TEXT  

Topical Mitomycin Chemotherapy for Conjunctival Malignant Melanoma and Primary Acquired Melanosis With Atypia: Clinical Experience With Histopathologic Observations
Demirci et al.
Arch Ophthalmol 2000;118:885-891.
ABSTRACT | FULL TEXT  

Immunohistochemical Localization of NQO1 in Epithelial Dysplasia and Neoplasia and in Donor Eyes
Schelonka et al.
IOVS 2000;41:1617-1622.
ABSTRACT | FULL TEXT  

Treatment of conjunctival squamous cell carcinoma with topical 5-fluorouracil
Midena et al.
Br J Ophthalmol 2000;84:268-272.
ABSTRACT | FULL TEXT  

Towards a more accurate assessment of the malignant potential in conjunctival melanosis
LEE
Br J Ophthalmol 1998;82:1227-1227.
FULL TEXT  

Surgical Management of Conjunctival Tumors: The 1994 Lynn B. McMahan Lecture
Shields et al.
Arch Ophthalmol 1997;115:808-815.
ABSTRACT